tiprankstipranks
Advertisement
Advertisement

PEPG Stock Latest News

PepGen: PGN-EDODM1 Multisystem Efficacy Potential Supports Buy Rating with Unchanged $20 Price Target
RatingsPepGen: PGN-EDODM1 Multisystem Efficacy Potential Supports Buy Rating with Unchanged $20 Price Target
3d ago
PEPG
PepGen Shareholders Back Directors and KPMG at 2026 Meeting
PremiumCompany Announcements
PepGen Shareholders Back Directors and KPMG at 2026 Meeting
1M ago
8K
PEPG
Craig-Hallum bullish on PepGen, initiates with a Buy
PremiumThe Fly
Craig-Hallum bullish on PepGen, initiates with a Buy
2M ago
PEPG
PepGen initiated with a Buy at Craig-Hallum
PremiumThe Fly
PepGen initiated with a Buy at Craig-Hallum
2M ago
PEPG
PepGen Highlights DM1 Program Progress in Updated Presentation
PremiumCompany Announcements
PepGen Highlights DM1 Program Progress in Updated Presentation
2M ago
8K
PEPG
PepGen files $400M mixed securities shelf
PremiumThe FlyPepGen files $400M mixed securities shelf
3M ago
PEPG
PepGen price target lowered to $4 from $5 at Wedbush
Premium
The Fly
PepGen price target lowered to $4 from $5 at Wedbush
3M ago
PEPG
PepGen reports Q1 EPS (26c), consensus (31c)
Premium
The Fly
PepGen reports Q1 EPS (26c), consensus (31c)
3M ago
PEPG
PepGen sees cash runway into 2H27
PremiumThe Fly
PepGen sees cash runway into 2H27
3M ago
PEPG
Video: Deals in food and pharmaceuticals headline busy morning of M&A
PremiumThe Fly
Video: Deals in food and pharmaceuticals headline busy morning of M&A
4M ago
UL
LLY
PepGen: Modest FREEDOM2 Efficacy, Regulatory Overhang, and Competitive Pressures Underscore Sell Rating
PremiumRatings
PepGen: Modest FREEDOM2 Efficacy, Regulatory Overhang, and Competitive Pressures Underscore Sell Rating
4M ago
PEPG
Buy Rating on PepGen: DM1 Program De-Risked by Stronger Underlying Biology and Upside from Higher-Dose Cohorts
PremiumRatings
Buy Rating on PepGen: DM1 Program De-Risked by Stronger Underlying Biology and Upside from Higher-Dose Cohorts
4M ago
PEPG
PepGen Reports Early Phase 2 FREEDOM2-DM1 Topline Data
PremiumCompany AnnouncementsPepGen Reports Early Phase 2 FREEDOM2-DM1 Topline Data
4M ago
8K
PEPG
Closing Bell Movers: Phreesia down over 20% after guidance cut
Premium
The Fly
Closing Bell Movers: Phreesia down over 20% after guidance cut
4M ago
CVV
PHR
PepGen down 46% at $2.30 after Phase 2 Freedom trial data
Premium
The Fly
PepGen down 46% at $2.30 after Phase 2 Freedom trial data
4M ago
PEPG
PepGen Inc trading resumes
PremiumThe Fly
PepGen Inc trading resumes
4M ago
PEPG
PepGen reports ‘promising’ topline results from MAD cohort
PremiumThe Fly
PepGen reports ‘promising’ topline results from MAD cohort
4M ago
PEPG
PepGen Inc trading halted, news pending
PremiumThe Fly
PepGen Inc trading halted, news pending
4M ago
PEPG
Midday Fly By: Stocks tumble as oil prices climb again
PremiumThe Fly
Midday Fly By: Stocks tumble as oil prices climb again
5M ago
BJ
GO
PepGen: Clinical and Safety Uncertainties, FDA Partial Hold, and Valuation Gap Support Underperform Rating
PremiumRatingsPepGen: Clinical and Safety Uncertainties, FDA Partial Hold, and Valuation Gap Support Underperform Rating
5M ago
PEPG
Closing Bell Movers: Veeva up 13%, Broadcom up 5% on earnings beat
Premium
The Fly
Closing Bell Movers: Veeva up 13%, Broadcom up 5% on earnings beat
5M ago
GO
AEO
PepGen Updates EDO Platform and DM1 Program Outlook
Premium
Company Announcements
PepGen Updates EDO Platform and DM1 Program Outlook
5M ago
8K
PEPG

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >